7 Documents disponibles écrits par cet auteur
This technical protocol outlines the key steps and considerations to be taken when deciding whether and how to set up a survey for monitoring DRID, related risk factors and preventive interventions among people who inject drugs (PWID). [Editor's[...]
T. HOLZMANN ; D. FRANGOULIDIS ; M. SIMON ; P. NOLL ; S. SCHMOLDT ; M. HANCZARUK ; G. GRASS ; M. PREGLER ; A. SING ; S. HORMANSDORFER ; H. BERNARD ; R. GRUNOW ; R. ZIMMERMANN ; W. SCHNEIDER-BRACHERT ; A. GESSNER ; U. REISCHL | 2012
Dans Eurosurveillance (Vol.17, n°26, 28 June 2012) Article : PériodiqueBlood cultures from a heroin user who died in June 2012, a few hours after hospital admission, due to acute septic disease, revealed the presence of Bacillus anthracis. This report describes the extended diagnosis by MALDI-TOF and real-time PCR [...]
M. MATICIC ; J. CERNOSA ; C. LOBODA ; J. TAMSE ; R. RIGONI ; E. DUFFELL ; I. INDAVE ; R. ZIMMERMANN ; L. DARRAGH ; J. MOURA ; A. LEICHT ; T. WINDELINCKX ; M. JAUFFRET-ROUSTIDE ; K. SCHIFFER ; T. TAMMI | 2024
Dans Harm Reduction Journal (Vol.21, 2024) Article : PériodiqueBACKGROUND: With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority[...]
H. FRASER ; N. K. MARTIN ; H. BRUMMER-KORVENKONTIO ; P. CARRIERI ; O. DALGARD ; J. DILLON ; D. GOLDBERG ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. A. MATSER ; M. MATICIC ; H. MIDGARD ; V. MRAVCIK ; A. OVREHUS ; M. PRINS ; J. REIMER ; G. ROBAEYS ; B. SCHULTE ; D. K. VAN SANTEN ; R. ZIMMERMANN ; P. VICKERMAN ; M. HICKMAN | 2018
Dans Journal of Hepatology (Vol.68, n°3, March 2018) Article : PériodiqueBACKGROUND & AIMS: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opio[...]
I. SPERLE ; T. SEYLER ; F. PERICOLI ; E. DUFFELL ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. KIVITE-URTANE ; C. SEGUIN-DEVAUX ; V. SYPSA ; R. ZIMMERMANN | 2025
Dans Eurosurveillance (Vol.30, n°30, 31 July 2025) Article : PériodiqueDrug-related infectious diseases (DRID), such as HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV), contribute to high morbidity and mortality among people who inject drugs (PWID). The European Union Drugs Agency (EUDA) is responsible for[...]
M. MATICIC ; Z. PIRNAT ; A. LEICHT ; R. ZIMMERMANN ; T. WINDELINCK ; M. JAUFFRET-ROUSTIDE ; E. DUFFELL ; T. TAMMI ; E. SCHATZ | 2020
Dans Harm Reduction Journal (Vol.17, 2020) Article : PériodiqueBackground: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) t[...]
L. WIESSING ; E. KALAMARA ; J. STONE ; P. ALTAN ; L. VAN BAELEN ; A. FOTIOU ; D. GARCIA ; J. GOULAO ; B. GUARITA ; V. HOPE ; M. JAUFFRET-ROUSTIDE ; L. JURGELAITIENE ; M. KABERG ; A. KAMARULZAMAN ; L. LEMSALU ; A. KIVITE-URTANE ; B. KOLARIC ; L. MONTANARI ; M. ROSINSKA ; L. SAVA ; I. HORVATH ; T. SEYLER ; V. SYPSA ; A. TARJAN ; I. YIASEMI ; R. ZIMMERMANN ; M. FERRI ; K. DOLAN ; A. UUSKULA ; P. VICKERMAN | 2021
Dans Eurosurveillance (Vol.26, n°49, 09 Decembe 2021) Article : PériodiqueBackground: People who inject drugs (PWID) are frequently incarcerated, which is associated with multiple negative health outcomes. Aim: We aimed to estimate the associations between a history of incarceration and prevalence of HIV and HCV infe[...]
Historique
